¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Privacy Management Software in Healthcare
»óǰÄÚµå : 1773868
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 387 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,112,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,338,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2030³â±îÁö 11¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 4¾ï 8,730¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 14.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠŬ¶ó¿ìµå µµÀÔÀº CAGR 12.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 5¾ï 9,100¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ÂÇÁ·¹¹Ì½º µðÇ÷ÎÀÌ¸ÕÆ® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 16.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 3,280¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 18.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2024³â¿¡ 1¾ï 3,280¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2¾ï 2,730¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 18.6%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 10.5%¿Í 12.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 11.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

ÇコÄɾ¼­ °³ÀÎÁ¤º¸ °ü¸® ¼ÒÇÁÆ®¿þ¾î°¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î´Â ÇコÄÉ¾î »ê¾÷¿¡¼­ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â·ÏÀÇ µðÁöÅÐÈ­, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ µµÀÔ, ¿ø°ÝÀÇ·áÀÇ È®´ë·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â µ¥ÀÌÅÍ À¯Ãâ, »çÀ̹ö °ø°Ý, ±ÔÁ¤ À§¹Ý°ú °ü·ÃµÈ À§Çè¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇØ º´¿ø, Áø·á¼Ò, Á¦¾à»ç, º¸Çè»ç´Â µ¥ÀÌÅÍ º¸È£ ÇÁ·ÎÅäÄÝ ÀÚµ¿È­, ȯÀÚ µ¿ÀÇ °ü¸®, HIPAA(ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü), GDPR(ÀÏ¹Ý µ¥ÀÌÅÍ º¸È£ ±ÔÁ¤), HITECH¹ý µî ¼¼°è ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ Áø´Ü, ¿þ¾î·¯ºí ÇコÄÉ¾î ±â±â, Ŭ¶ó¿ìµå ±â¹Ý ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ µîÀåÀ¸·Î °­·ÂÇÑ ÇÁ¶óÀ̹ö½Ã ÇÁ·¹ÀÓ¿öÅ©ÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ÇコÄɾî Á¶Á÷ÀÌ µ¥ÀÌÅÍ º¸¾ÈÀ» °­È­Çϰí, ȯÀÚÀÇ ±â¹ÐÀ» º¸È£Çϰí, ÀçÁ¤Àû À§Çè°ú ÆòÆÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ³ë·ÂÇϰí ÀÖ´Â °¡¿îµ¥, ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î´Â ÇコÄɾî Á¤º¸ º¸È£¿¡ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î äÅÃÀ» ¹æÇØÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

ÀÌ·¯ÇÑ Á߿伺¿¡µµ ºÒ±¸Çϰí, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î µµÀÔÀº ÅëÇÕÀÇ º¹À⼺, ±ÔÁ¦ ºÐÀý, ÁøÈ­ÇÏ´Â »çÀ̹ö º¸¾È À§Çù µî ¿©·¯ °¡Áö µµÀü °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä À庮 Áß Çϳª´Â ÇÁ¶óÀ̹ö½Ã ¼Ö·ç¼Ç°ú ·¹°Å½Ã EHR ½Ã½ºÅÛ ¹× À̱âÁ¾ ÇコÄɾî IT ÀÎÇÁ¶ó¿ÍÀÇ ÅëÇÕÀÌ ¾î·Á¿ö ÄÄÇöóÀ̾𽺠ÀÌÇà¿¡ ºñÈ¿À²¼ºÀ» ÃÊ·¡ÇÑ´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ, °¢±¹ÀÇ ÇコÄÉ¾î ±ÔÁ¦°¡ ¿ªµ¿ÀûÀ¸·Î º¯È­ÇÔ¿¡ µû¶ó ÀÇ·á±â°üÀº µ¥ÀÌÅÍ º¸È£ ¹× ȯÀÚ µ¿ÀÇ¿Í °ü·ÃµÈ ´Ù¾çÇÑ ¹ýÀû ¿ä°Ç¿¡ ´ëÀÀÇØ¾ß ÇϹǷΠ´õ¿í º¹ÀâÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â°üÀ» ´ë»óÀ¸·Î ÇÑ ·£¼¶¿þ¾î °ø°Ý, ÇÇ½Ì »ç±â µî »çÀ̹ö º¸¾È À§ÇùÀº °è¼Ó ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î°¡ »õ·Î¿î À§Çè¿¡ ´ëÀÀÇÏ´Â °ÍÀº ¾î·Á¿î ÀÏÀÔ´Ï´Ù. ƯÈ÷ ¼Ò±Ô¸ð ÀÇ·á ¼­ºñ½º Á¦°øÀÚ³ª Áö¹æ º´¿øÀÇ °æ¿ì, °í±Þ ÇÁ¶óÀ̹ö½Ã ¼Ö·ç¼ÇÀÇ ³ôÀº µµÀÔ ºñ¿ëµµ ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á Àü¹®°¡µéÀº µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¸ð¹ü »ç·Ê¿¡ ´ëÇÑ ÃæºÐÇÑ ±³À°À» ¹ÞÁö ¸øÇÑ °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ ÀÖÀ½¿¡µµ ºÒ±¸Çϰí Ãë¾à¼ºÀ» ÃÊ·¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â »óÈ£¿î¿ë¼º °­È­, ±ÔÁ¦ Á¶Á¤, ºñ¿ë È¿À²ÀûÀÎ ¼ÒÇÁÆ®¿þ¾î ¿É¼Ç, Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã °ü¸®¸¦ º¸ÀåÇϱâ À§ÇÑ Àη ±³À°¿¡ ´ëÇÑ ÅõÀÚ È®´ë°¡ ÇÊ¿äÇÕ´Ï´Ù.

AI¿Í ºí·ÏüÀÎÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÇÁ¶óÀ̹ö½Ã °ü¸®¸¦ ¾î¶»°Ô °­È­ÇÒ ¼ö ÀÖÀ»±î?

ÀΰøÁö´É(AI)°ú ºí·ÏüÀÎÀÇ ±â¼ú ¹ßÀüÀº ÇコÄÉ¾î ºÐ¾ßÀÇ ÇÁ¶óÀ̹ö½Ã °ü¸®¸¦ º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀ̸ç ÁøÈ­ÇÏ´Â µ¥ÀÌÅÍ º¸È£ ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï º¯È­½Ã۰í ÀÖÀ¸¸ç, AI ±â¹Ý ÇÁ¶óÀ̹ö½Ã ÅøÀº ÄÄÇöóÀ̾𽺠¿öÅ©Ç÷ο츦 ÀÚµ¿È­Çϰí, ȯÀÚ µ¥ÀÌÅÍ Á¢±Ù ÀÌ»ó ¡Èĸ¦ °¨ÁöÇϰí, ÀáÀçÀûÀÎ µ¥ÀÌÅÍ À¯ÃâÀ» »çÀü¿¡ ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¢±ÙÀÇ ÀÌ»ó ¡Èĸ¦ °¨ÁöÇϰí ÀáÀçÀûÀÎ µ¥ÀÌÅÍ À¯ÃâÀ» »çÀü¿¡ ¿¹ÃøÇÕ´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀº ºÎÁ¤ ¾×¼¼½º ÆÐÅÏÀ» ½Äº°Çϰí Àǽɽº·¯¿î Ȱµ¿À» ½Ç½Ã°£À¸·Î Ç¥½ÃÇÏ¿© À§Çè Æò°¡¸¦ °­È­ÇÕ´Ï´Ù. ºí·ÏüÀÎ ±â¼úÀº Åõ¸í¼º°ú ¹«°á¼ºÀ» À¯ÁöÇϸ鼭 ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ¾ÈÀüÇÏ°í ºÐ»êµÈ µ¥ÀÌÅÍ °øÀ¯¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á ÇコÄÉ¾î µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ½º¸¶Æ® °è¾àÀº ÇÁ¶óÀ̹ö½Ã °ü¸® ½Ã½ºÅÛ¿¡ ÅëÇյǾî ȯÀÚÀÇ µ¿ÀÇ ÀýÂ÷¸¦ ÀÚµ¿È­Çϰí, ¸íÈ®ÇÑ ½ÂÀÎÀ» ¹ÞÀº °æ¿ì¿¡¸¸ µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI¸¦ Ȱ¿ëÇÑ ÀÚ¿¬¾î ó¸®(NLP)´Â º¹ÀâÇÑ ¹ý±Ô¸¦ ºÐ¼®ÇÏ¿© ÇコÄɾî Á¶Á÷¿¡ ½Ç¿ëÀûÀÎ ÄÄÇöóÀ̾𽺠°¡À̵å¶óÀÎÀ¸·Î ¹ø¿ªÇÔÀ¸·Î½á ±ÔÁ¦ Áؼö¸¦ °£¼ÒÈ­ÇÕ´Ï´Ù. AI¿Í ºí·ÏüÀÎ ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó, ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î´Â ´õ¿í Áö´ÉÀûÀ̰í ź·ÂÀûÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. °ü¸® ¼ÒÇÁÆ®¿þ¾î´Â ´õ¿í Áö´ÉÀûÀ̰í ź·ÂÀûÀ̸ç, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¸®½ºÅ©¸¦ ÁÙÀ̴µ¥ ´õ¿í È¿°úÀûÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ÇコÄÉ¾î ºÐ¾ß ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã °­È­, ÀÇ·á µ¥ÀÌÅ͸¦ ³ë¸®´Â »çÀ̹ö À§ÇùÀÇ Áõ°¡, µðÁöÅÐ Çコ ±â¼úÀÇ ±Þ¼ÓÇÑ Ã¤Åà µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.ÀÇ ½ÃÇàÀ¸·Î ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ÄÄÇöóÀ̾𽺸¦ ÁؼöÇÏ°í ¸·´ëÇÑ ¹ú±ÝÀ» ÇÇÇϱâ À§ÇØ °í±Þ °³ÀÎÁ¤º¸ º¸È£ °ü¸® ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÒ ¼ö¹Û¿¡ ¾ø´Â »óȲÀÔ´Ï´Ù. ¿ø°ÝÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ ÀÇ·á µ¥ÀÌÅͰ¡ µðÁöÅÐ Ç÷§Æû °£¿¡ Á¡Á¡ ´õ ¸¹ÀÌ ±³È¯µÇ°í Àֱ⠶§¹®¿¡ ¾ÈÀüÇÑ µ¥ÀÌÅÍ °Å¹ö³Í½º ÇÁ·¹ÀÓ¿öÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ±Ç¸®¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ±â°üÀº º¸´Ù Åõ¸íÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÇÁ¶óÀ̹ö½Ã °ü¸®¸¦ µµÀÔÇØ¾ß ÇÏ´Â »óȲµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI¸¦ Ȱ¿ëÇÑ ÇコÄÉ¾î ºÐ¼®°ú ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ¹Î°¨ÇÑ À¯Àüü ¹× »ýüÀÎ½Ä µ¥ÀÌÅ͸¦ º¸È£ÇÏ´Â °­·ÂÇÑ ÇÁ¶óÀ̹ö½Ã ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇコÄɾîÀÇ µðÁöÅÐ ÀüȯÀÌ Áö¼ÓµÊ¿¡ µû¶ó ÇÁ¶óÀ̹ö½Ã °ü¸® ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÇ°í, ÇコÄÉ¾î ºÎ¹®À» À§ÇÑ ¾ÈÀüÇϰí È®Àå °¡´ÉÇÏ¸ç ±ÔÁ¦¸¦ ÁؼöÇÏ´Â ¸ÂÃãÇü µ¥ÀÌÅÍ º¸È£ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çõ½ÅÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

Àü°³(Ŭ¶ó¿ìµå Àü°³, ¿ÂÇÁ·¹¹Ì½º Àü°³), ¿ëµµ(µ¥ÀÌÅÍ ¹ß°ß¡¤¸ÅÇÎ ¿ëµµ, µ¥ÀÌÅÍ ´ë»ó ¾×¼¼½º ¿ä±¸ ¿ëµµ, ÇÁ¶óÀ̹ö½Ã ¿µÇâ Æò°¡ ¿ëµµ, µ¿ÀÇ¡¤±âÈ£ °ü¸® ¿ëµµ, ÀνôøÆ®¡¤´©¼³ °ü¸® ¿ëµµ, º¥´õ¡¤Á¦3ÀÚ ¸®½ºÅ© °ü¸® ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(ÀÇ·á Á¦°øÀÚ ÃÖÁ¾ ¿ëµµ, ÀÇ·áºñ ÁöºÒÀÚ ÃÖÁ¾ ¿ëµµ, »ý¸í°úÇÐ ±â¾÷ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡°¡ ¼±º°ÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Privacy Management Software in Healthcare Market to Reach US$1.1 Billion by 2030

The global market for Privacy Management Software in Healthcare estimated at US$487.3 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$591.0 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 16.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$132.8 Million While China is Forecast to Grow at 18.6% CAGR

The Privacy Management Software in Healthcare market in the U.S. is estimated at US$132.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$227.3 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.5% and 12.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global Privacy Management Software in Healthcare Market - Key Trends & Drivers Summarized

Why Is Privacy Management Software Becoming Essential in Healthcare?

Privacy management software has become a critical component in the healthcare industry as organizations handle increasing volumes of sensitive patient data while complying with stringent privacy regulations. With the digitization of healthcare records, the adoption of electronic health records (EHRs), and the expansion of telemedicine, healthcare providers face growing risks related to data breaches, cyberattacks, and regulatory non-compliance. Privacy management software enables hospitals, clinics, pharmaceutical companies, and insurance providers to automate data protection protocols, manage patient consent, and ensure compliance with global regulations such as HIPAA (Health Insurance Portability and Accountability Act), GDPR (General Data Protection Regulation), and the HITECH Act. The rise of AI-driven diagnostics, wearable health devices, and cloud-based healthcare solutions has further intensified the need for robust privacy frameworks. As healthcare organizations seek to enhance data security, protect patient confidentiality, and mitigate financial and reputational risks, privacy management software is playing a vital role in safeguarding healthcare information.

What Challenges Are Hindering the Adoption of Privacy Management Software in Healthcare?

Despite its importance, the adoption of privacy management software in healthcare faces multiple challenges, including integration complexities, regulatory fragmentation, and evolving cybersecurity threats. One of the key barriers is the difficulty of integrating privacy solutions with legacy EHR systems and disparate healthcare IT infrastructures, leading to inefficiencies in compliance enforcement. The dynamic nature of healthcare regulations across different countries adds another layer of complexity, requiring healthcare organizations to navigate varying legal requirements for data protection and patient consent. Additionally, cybersecurity threats such as ransomware attacks and phishing schemes targeting healthcare institutions continue to evolve, making it challenging for privacy management software to keep pace with emerging risks. The high cost of implementing advanced privacy solutions, particularly for smaller healthcare providers and rural hospitals, also limits market penetration. Moreover, healthcare professionals often lack sufficient training in data privacy best practices, leading to vulnerabilities despite the presence of software solutions. Addressing these challenges requires enhanced interoperability, regulatory alignment, cost-effective software options, and increased investment in workforce training to ensure comprehensive data privacy management.

How Are AI and Blockchain Enhancing Privacy Management in Healthcare?

Technological advancements in artificial intelligence (AI) and blockchain are transforming privacy management in healthcare, making it more secure, efficient, and adaptable to evolving data protection needs. AI-driven privacy tools are automating compliance workflows, detecting anomalies in patient data access, and predicting potential data breaches before they occur. Machine learning algorithms are enhancing risk assessment by identifying patterns of unauthorized access and flagging suspicious activities in real time. Blockchain technology is revolutionizing healthcare data privacy by enabling secure, decentralized data sharing between healthcare providers while maintaining transparency and integrity. Smart contracts are being integrated into privacy management systems to automate patient consent processes, ensuring that data is accessed only with explicit authorization. Additionally, AI-powered natural language processing (NLP) is simplifying regulatory compliance by analyzing complex legal texts and translating them into actionable compliance guidelines for healthcare organizations. As AI and blockchain technologies continue to advance, privacy management software in healthcare is becoming more intelligent, resilient, and effective in mitigating data privacy risks.

What Is Driving the Growth of the Privacy Management Software in Healthcare Market?

The growth in the privacy management software in healthcare market is driven by several factors, including increasing regulatory scrutiny, rising cyber threats targeting medical data, and the rapid adoption of digital health technologies. The enforcement of stringent data protection laws such as HIPAA, GDPR, and CCPA has compelled healthcare providers to invest in advanced privacy management solutions to ensure compliance and avoid hefty penalties. The surge in telehealth and remote patient monitoring has further accelerated demand for secure data governance frameworks, as healthcare data is increasingly exchanged across digital platforms. The growing awareness among patients about their data privacy rights has also contributed to market expansion, prompting healthcare organizations to implement more transparent and user-friendly privacy controls. Additionally, the rise of AI-powered healthcare analytics and personalized medicine has fueled the need for robust privacy solutions to protect sensitive genomic and biometric data. As healthcare continues its digital transformation, the demand for privacy management software is expected to grow, driving innovation in secure, scalable, and regulatory-compliant data protection solutions tailored for the healthcare sector.

SCOPE OF STUDY:

The report analyzes the Privacy Management Software in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud Deployment, On-Premise Deployment); Application (Data Discovery & Mapping Application, Data Subject Access Request Application, Privacy Impact Assessment Application, Consent & Preference Management Application, Incident & Breach Management Application, Vendor & Third Party Risk Management Application, Other Applications); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Life Science Companies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â